A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma
Clinical trial NCT04996004 · TERMINATED
Trial details
- NCT number
- NCT04996004
- Sponsor
- Pfizer
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-22
- Primary completion
- 2023-12-07
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.